Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study
about
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancerProton pump inhibitors and an emerging epidemic of gastric fundic gland polyposisEvidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark.Long-term proton pump inhibitor use and gastrointestinal cancerPrescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyPantoprazole, a proton pump inhibitor, increases orthodontic tooth movement in ratsAdverse effects of long-term proton pump inhibitor therapy.Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies.Proton pump inhibitors: Risks of long-term use.Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark.Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control studyHypergastrinemiaAtrophic gastritis and the risk of incident colorectal cancer.Colorectal cancer risk in relation to use of acid suppressive medications.Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.Long-term acid inhibition: benefits and harms.Prescribing proton pump inhibitors: is it time to pause and rethink?Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?Indications and safety of proton pump inhibitor drug use in patients with cancer.Proton pump inhibitors and the risk of colorectal cancer.Paradoxically augmented anti-tumorigenic action of proton pump inhibitor and GastrininAPCMin/+ intestinal polyposis model.Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.Proton-pump inhibitors: understanding the complications and risks.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionEffects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects.Gastroprotective effect of a flavone from Lonchocarpus araripensis Benth. (Leguminosae) and the possible mechanism.Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors.Proton pump inhibitors on pancreatic cancer risk and survival.Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.
P2860
Q24201720-277B0FCB-35BA-48BC-BED3-F61806547EFFQ24648651-BA254E08-2E46-455F-8F75-2DB56759F1E4Q30249468-60FC1BAD-1C5F-4DAD-AA0C-BA446CC2D1B6Q33723545-B6AC1B9C-9C28-4A04-9EAE-718420197A44Q33727006-4063D149-814A-4FA2-B6EF-C645ECC5138BQ33889458-0ED857C3-4665-46F9-9A4D-A6B3B8298714Q34065780-485DE184-5269-421C-8684-BD4DEFE04479Q34167899-BCCD3B36-344F-433A-971E-7AD0EDA75F58Q34463547-D9EB5B4C-DB14-434F-9CF6-7B425C3E9C5EQ34549406-603B5BC7-853E-4122-A60C-3789D276C18AQ35116562-D83E75C3-EFD5-4D2B-82B0-69B6F31E8773Q35623324-2EDA2B3D-19F0-462C-A542-62EC30E2E390Q35653793-E235E416-3728-4F90-85B9-349F5FC60FF1Q35923382-56B70A86-C474-4DD3-9B2C-B95479161B9CQ36434231-EFB71798-8ADF-4B32-A89E-D769CD79E3A2Q36949692-F0571590-2AF9-47D7-BCC2-93DB2D834719Q37222668-EBEBC1EB-9461-483C-A6B8-C6A1B9026959Q37524960-E712743B-269E-485E-A0BA-E7D0BAEC28F4Q37957704-2069C3DB-BA54-440C-B048-0764C64C3EB5Q37987204-BF842C99-23E2-42DE-B60A-547335013362Q38011261-61833832-EB77-4B22-A938-5C6984A0041EQ38104388-A385295A-EFD5-4D03-9E39-7EF3C4C3CBCCQ38459132-AE478910-FC0A-4A88-8B60-33BB762974FDQ39021463-A8540117-4DB0-4E88-86F6-AA9AFE433BB2Q39234055-69EDB7CD-20E3-449D-9A2B-20815DF9A5F0Q41146448-5052BBD4-50EC-4C55-9025-750F3DA10732Q41996131-A7F5FBD7-CC38-4CF7-BED7-29D743D551E1Q42371575-63ADC8F1-2EC6-435C-B7F7-CC7E1BE303D7Q46076164-9B8531D2-4DD2-4967-809E-F24E6B2F95ADQ46745356-7A2D668E-3C8F-4807-8FF6-3DB7DBA00CD0Q47197069-0B1C1D86-85AD-409C-B850-4233881F1685Q47350333-F77EBC9A-53D4-40E3-8087-1A11A9C88F25Q50206074-654B50D9-73B6-45D9-B9EE-1E80F7B4DEDCQ50970848-277D8ECF-6183-4A4A-B076-36AFD2E121FEQ53059964-896519F4-A3EA-48A7-B826-68ACCC9A4CDAQ55493690-6C3E6186-2944-4DD2-B67D-F6ED9304B94D
P2860
Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Proton pump inhibitor use and ...... tion-based, case-control study
@ast
Proton pump inhibitor use and ...... tion-based, case-control study
@en
Proton pump inhibitor use and ...... tion-based, case-control study
@nl
type
label
Proton pump inhibitor use and ...... tion-based, case-control study
@ast
Proton pump inhibitor use and ...... tion-based, case-control study
@en
Proton pump inhibitor use and ...... tion-based, case-control study
@nl
prefLabel
Proton pump inhibitor use and ...... tion-based, case-control study
@ast
Proton pump inhibitor use and ...... tion-based, case-control study
@en
Proton pump inhibitor use and ...... tion-based, case-control study
@nl
P2093
P3181
P1433
P1476
Proton pump inhibitor use and ...... tion-based, case-control study
@en
P2093
Douglas J Robertson
Heidi Larsson
John A Baron
Lars Pedersen
Søren Friis
P304
P3181
P356
10.1053/J.GASTRO.2007.06.014
P407
P577
2007-09-01T00:00:00Z